Common Genetic Variant Risk Score Is Associated With Drug-Induced QT Prolongation and Torsade de Pointes Risk: A Pilot Study.
about
Investigational antiarrhythmic agents: promising drugs in early clinical development.Long QT Syndrome Unveiled by a Fatal Combination of Medications and Electrolyte Abnormalities.Have the Findings from Clinical Risk Prediction and Trials Any Key Messages for Safety Pharmacology?Translating New Science Into the Drug Review Process: The US FDA's Division of Applied Regulatory Science.Mechanisms Underlying the Actions of Antidepressant and Antipsychotic Drugs That Cause Sudden Cardiac Arrest
P2860
Common Genetic Variant Risk Score Is Associated With Drug-Induced QT Prolongation and Torsade de Pointes Risk: A Pilot Study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Common Genetic Variant Risk Sc ...... e Pointes Risk: A Pilot Study.
@en
type
label
Common Genetic Variant Risk Sc ...... e Pointes Risk: A Pilot Study.
@en
prefLabel
Common Genetic Variant Risk Sc ...... e Pointes Risk: A Pilot Study.
@en
P2093
P2860
P50
P1433
P1476
Common Genetic Variant Risk Sc ...... de Pointes Risk: A Pilot Study
@en
P2093
Christopher Newton-Cheh
Dan M Roden
David G Strauss
Gulum Kosova
Jay W Mason
Lars Johannesen
Michael A Rosenberg
Peter Weeke
Ray Woosley
P2860
P304
P356
10.1161/CIRCULATIONAHA.116.023980
P407
P577
2017-02-17T00:00:00Z